For research use only. Not for therapeutic Use.
RCM-1(CAT: I019980), as a forkhead box M1 (FOXM1) inhibitor, inhibits the activity of FOXM1, a transcription factor involved in cell proliferation and tumorigenesis. RCM-1 has demonstrated an EC50 of 0.72 μM in U2OS cells and effectively blocks the nuclear localization of FOXM1, leading to increased proteasomal degradation of the protein. The application of RCM-1 in asthma and other chronic airway diseases research suggests its potential as a therapeutic target for these conditions. Further research and studies are necessary to explore its efficacy and safety in the context of asthma and chronic airway diseases.
Catalog Number | I019980 |
CAS Number | 339163-65-4 |
Molecular Formula | C₂₀H₁₂N₂OS₄ |
Purity | ≥95% |
Reference | [1]. Lifeng Sun, et al. The FOXM1 inhibitor RCM-1 suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice. Sci Signal. 2017 Apr 18;10(475):eaai8583. |